カテゴリ： GlobalData, イギリス, 企業調査

LivaNova PLC (LIVN)：企業の製品パイプライン分析2018

◆英語タイトル：LivaNova PLC (LIVN) - Product Pipeline Analysis, 2018 Update
◆商品コード：DATA904C12750
◆発行会社（調査会社）：GlobalData
◆発行日：2018年12月
◆ページ数：58
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イギリス
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD1,500 ⇒換算￥222,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD2,250 ⇒換算￥333,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
LivaNova PLC (LivaNova) is a medical technology company that offers medical devices for cardiac surgery and neuromodulation. The company’s neuromodulation provides vagus nerve stimulation therapy system, an implantable device for the people affected by treatment-resistant epilepsy, depression, heart failure and other chronic disorders. Its cardiovascular surgery products include oxygenators, heart-lung machines, perfusion tubing systems, cannulae and accessories; systems for auto transfusion and autologous blood washing; surgical tissue and mechanical valve replacements, and repair products for damaged or diseased heart valves. The company offers its solutions to patients, healthcare professionals and healthcare systems. LivaNova is headquartered in London, England, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company LivaNova PLC
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
LivaNova PLC Company Overview 6
LivaNova PLC Company Snapshot 6
LivaNova PLC Pipeline Products and Ongoing Clinical Trials Overview 6
LivaNova PLC – Pipeline Analysis Overview 9
LivaNova PLC – Key Facts 9
LivaNova PLC – Major Products and Services 10
LivaNova PLC Pipeline Products by Development Stage 11
LivaNova PLC Ongoing Clinical Trials by Trial Status 14
LivaNova PLC Pipeline Products Overview 16
Aspire NP 16
Aspire NP Product Overview 16
Caisson TMVR System 17
Caisson TMVR System Product Overview 17
Caisson TMVR System Clinical Trial 18
Centro Generator 19
Centro Generator Product Overview 19
CentroSR Generator 20
CentroSR Generator Product Overview 20
Equilia 21
Equilia Product Overview 21
Griffin – Pulse Generator 22
Griffin – Pulse Generator Product Overview 22
Intense Neuromodulation System – Heart Failure 23
Intense Neuromodulation System – Heart Failure Product Overview 23
LBATS 24
LBATS Product Overview 24
Microburst VNS Stimulator 25
Microburst VNS Stimulator Product Overview 25
Microburst VNS Stimulator Clinical Trial 26
Nerve Wrap 27
Nerve Wrap Product Overview 27
New Oxy Apex HP Oxygenator 28
New Oxy Apex HP Oxygenator Product Overview 28
Next Generation ECMO System 29
Next Generation ECMO System Product Overview 29
Next Generation Wand – VNS Therapy 30
Next Generation Wand – VNS Therapy Product Overview 30
NINO 31
NINO Product Overview 31
Pediatric pVAD 32
Pediatric pVAD Product Overview 32
Perceval S – Extended Indications 33
Perceval S – Extended Indications Product Overview 33
Perceval S – Extended Indications Clinical Trial 34
Perceval Sutureless Heart Valve 35
Perceval Sutureless Heart Valve Product Overview 35
Perceval Sutureless Heart Valve Clinical Trial 36
Percutaneous Mitral Valve Repair Device 38
Percutaneous Mitral Valve Repair Device Product Overview 38
Percutaneous Mitral Valve Replacement Device 39
Percutaneous Mitral Valve Replacement Device Product Overview 39
PhoenixRF SR 40
PhoenixRF SR Product Overview 40
ProGuardian System 41
ProGuardian System Product Overview 41
Remote Monitoring System V2 42
Remote Monitoring System V2 Product Overview 42
Spiderflash AFIB 43
Spiderflash AFIB Product Overview 43
VITARIA System – Chronic Heart Failure 44
VITARIA System – Chronic Heart Failure Product Overview 44
VITARIA System – Chronic Heart Failure Clinical Trial 45
LivaNova PLC – Key Competitors 46
LivaNova PLC – Key Employees 47
LivaNova PLC – Locations And Subsidiaries 48
Head Office 48
Other Locations & Subsidiaries 48
Recent Developments 49
LivaNova PLC , Recent Developments 49
Jun 14, 2018: LivaNova Receives FDA Clearance and Completes First Implant For Its MEMO 4D Semi-rigid Mitral Annuloplasty Ring 49
Jun 14, 2018: LivaNova Receives FDA Clearance and Completes First Implant For Its MEMO 4D Semi-rigid Mitral Annuloplasty Ring 49
Jun 13, 2018: LivaNova Welcomes William Kozy to Board of Directors 50
May 30, 2018: LivaNova Comments on the U.S. Centers for Medicare & Medicaid Services’ Reconsideration of its National Coverage Determination for VNS Therapy for Treatment-Resistant Depression 50
Apr 26, 2018: LivaNova Announces One-Millionth Inspire Adult Oxygenator Patient 50
Apr 17, 2018: LivaNova Receives CE Mark for VNS Therapy SenTiva Generator and Next-Generation Programming System for Treatment of Epilepsy 51
Mar 29, 2018: LivaNova Bicarbon Aortic Valves Receive CE Mark for Expanded Use Labeling with Lower-Dose Blood Thinners in Low-Risk Patients 51
Mar 28, 2018: LivaNova Commences Clinical Study to Evaluate Treatment Outcomes for Novel Microburst VNS Therapy System 52
Mar 22, 2018: LivaNova Announces Enrollment for PERFECT Perceval Valve Clinical Trial in China 52
Feb 28, 2018: LivaNova Announces Fourth Quarter and Full-Year 2017 Results 53
Appendix 55
Methodology 55
About GlobalData 58
Contact Us 58
Disclaimer 58

List of Tables
LivaNova PLC Pipeline Products and Ongoing Clinical Trials Overview 6
LivaNova PLC Pipeline Products by Equipment Type 7
LivaNova PLC Pipeline Products by Indication 8
LivaNova PLC Ongoing Clinical Trials by Trial Status 8
LivaNova PLC , Key Facts 9
LivaNova PLC , Major Products and Services 10
LivaNova PLC Number of Pipeline Products by Development Stage 11
LivaNova PLC Pipeline Products Summary by Development Stage 12
LivaNova PLC Ongoing Clinical Trials by Trial Status 14
LivaNova PLC Ongoing Clinical Trials Summary 15
Aspire NP - Product Status 16
Aspire NP - Product Description 16
Caisson TMVR System - Product Status 17
Caisson TMVR System - Product Description 17
Caisson TMVR System - A Clinical Study to Evaluate Caisson Transcatheter Mitral Valve Replacement (TMVR) System in Subjects with Mitral Regurgitation 18
Caisson TMVR System - Clinical Investigation of the Caisson TransCather Mitral Valve Replacement (TMVR) System for Percutaneous Mitral Valve Replacement 18
Caisson TMVR System - Percutaneous Mitral Valve Replacement Evaluation Utilizing IDE Early Feasibility Study (PRELUDE) 18
Centro Generator - Product Status 19
Centro Generator - Product Description 19
CentroSR Generator - Product Status 20
CentroSR Generator - Product Description 20
Equilia - Product Status 21
Equilia - Product Description 21
Griffin - Pulse Generator - Product Status 22
Griffin - Pulse Generator - Product Description 22
Intense Neuromodulation System - Heart Failure - Product Status 23
Intense Neuromodulation System - Heart Failure - Product Description 23
LBATS - Product Status 24
LBATS - Product Description 24
Microburst VNS Stimulator - Product Status 25
Microburst VNS Stimulator - Product Description 25
Microburst VNS Stimulator - Microburst VNS Therapy Feasibility Study in Subjects with Refractory Epilepsy 26
Nerve Wrap - Product Status 27
Nerve Wrap - Product Description 27
New Oxy Apex HP Oxygenator - Product Status 28
New Oxy Apex HP Oxygenator - Product Description 28
Next Generation ECMO System - Product Status 29
Next Generation ECMO System - Product Description 29
Next Generation Wand - VNS Therapy - Product Status 30
Next Generation Wand - VNS Therapy - Product Description 30
NINO - Product Status 31
NINO - Product Description 31
Pediatric pVAD - Product Status 32
Pediatric pVAD - Product Description 32
Perceval S – Extended Indications - Product Status 33
Perceval S – Extended Indications - Product Description 33
Perceval S – Extended Indications - Behavior of Valve Leaflets and the Incidence of Reduced Mobility Post-surgical Aortic Valve Implant 34
Perceval Sutureless Heart Valve - Product Status 35
Perceval Sutureless Heart Valve - Product Description 35
Perceval Sutureless Heart Valve - Behavior of Valve Leaflets and the Incidence of Reduced Mobility Post-surgical Aortic Valve Implant 36
Perceval Sutureless Heart Valve - PERCEVAL S Valve Clinical Study for Chinese Registration 36
Perceval Sutureless Heart Valve - Perceval S Valve Clinical Trial for Extended CE Mark 36
Perceval Sutureless Heart Valve - Perceval Sutureless Implant Versus Standard-aortic Valve Replacement A Controlled Randomized Trial in the Surgical Treatment of Aortic Valve Disease 37
Perceval Sutureless Heart Valve - Sizing of the PERCEVAL Sutureless Aortic Valve Prosthesis Using the CT: A Feasibility Study 37
Percutaneous Mitral Valve Repair Device - Product Status 38
Percutaneous Mitral Valve Repair Device - Product Description 38
Percutaneous Mitral Valve Replacement Device - Product Status 39
Percutaneous Mitral Valve Replacement Device - Product Description 39
PhoenixRF SR - Product Status 40
PhoenixRF SR - Product Description 40
ProGuardian System - Product Status 41
ProGuardian System - Product Description 41
Remote Monitoring System V2 - Product Status 42
Remote Monitoring System V2 - Product Description 42
Spiderflash AFIB - Product Status 43
Spiderflash AFIB - Product Description 43
VITARIA System - Chronic Heart Failure - Product Status 44
VITARIA System - Chronic Heart Failure - Product Description 44
VITARIA System - Chronic Heart Failure - Autonomic Regulation Therapy to Enhance Myocardial Function and Reduce Progression of Heart Failure with Reduced Ejection Fraction 45
LivaNova PLC , Key Employees 47
LivaNova PLC , Subsidiaries 48
Glossary 57

List of Figures
LivaNova PLC Pipeline Products by Equipment Type 7
LivaNova PLC Pipeline Products by Development Stage 11
LivaNova PLC Ongoing Clinical Trials by Trial Status 14

★海外企業調査レポート[LivaNova PLC (LIVN)：企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Levi Strauss & Co (LEVI)：企業の財務・戦略的SWOT分析
    Levi Strauss & Co (LEVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • PhotoMedex Inc (PHMD)-医療機器分野：企業M&A・提携分析
    Summary PhotoMedex Inc (PhotoMedex) is a medical device company that provides dermatological solutions. The company offers Neova, Tricomin and IAMIN products. Its products are used in the treatment of skin diseases and conditions such as psoriasis, vitiligo, acne, actinic keratosis. PhotoMedex provi …
  • Wells Fargo & Company：企業の戦略・SWOT・財務情報
    Wells Fargo & Company - Strategy, SWOT and Corporate Finance Report Summary Wells Fargo & Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • First Electric Cooperative Corporation：企業の発電所・SWOT分析2018
    First Electric Cooperative Corporation - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informati …
  • Atomenergoprom：企業の戦略的SWOT分析
    Atomenergoprom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • MaaT Pharma：製薬・医療：M&Aディール及び事業提携情報
    Summary MaaT Pharma (MaaT) is a biotechchnology company that develop novel treatments for Gut Microbiota - dysbiosis related diseases. The company focuses on developing MaaT001, an innovative live frozen inoculum suspension and MaaT002, an innovative device for stool collection and storage. It also …
  • Ghella SpA：企業の戦略・SWOT・財務情報
    Ghella SpA - Strategy, SWOT and Corporate Finance Report Summary Ghella SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Abivax SA (ABVX)：企業の財務・戦略的SWOT分析
    Summary Abivax SA (Abivax) is a biotechnology company that develops and commercializes anti-viral therapies and therapeutic vaccines for the treatment of infectious and viral diseases. The company’s pipeline products include ABX464, ABX544 and ABX196. Its ABX464 is an oral small molecule to induce f …
  • Entertainment One Ltd.
    Entertainment One Ltd. - Strategy, SWOT and Corporate Finance Report Summary Entertainment One Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Ascoma Group：企業の戦略・SWOT・財務情報
    Ascoma Group - Strategy, SWOT and Corporate Finance Report Summary Ascoma Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Oneida Ltd.：企業の戦略的SWOT分析
    Oneida Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Quadrise Fuels International Plc (QFI)：企業の財務・戦略的SWOT分析
    Quadrise Fuels International Plc (QFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • C&C Group plc：戦略・SWOT・企業財務分析
    C&C Group plc - Strategy, SWOT and Corporate Finance Report Summary C&C Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Matrix Service Co：企業の戦略・SWOT・財務分析
    Matrix Service Co - Strategy, SWOT and Corporate Finance Report Summary Matrix Service Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Shermco Industries, Inc.：電力：M&Aディール及び事業提携情報
    Summary Shermco Industries, Inc. (Shermco), a member of the GFI Energy Group of Oaktree Capital Management LP, is an independent service company that provides electrical maintenance, repair, testing, and analysis services for electrical systems and equipment. It also offers industrial contracting, u …
  • Uscom Ltd (UCM)：企業の製品パイプライン分析
    Summary Uscom Ltd (Uscom) is a medical device company which focuses on the development, design, manufacture and marketing of non-invasive cardiovascular and pulmonary monitoring technologies. Uscom’s product portfolio includes its flagship product USCOM 1A (ultrasonic cardiac output monitor) non-inv …
  • Select Medical Holdings Corp (SEM)：企業の財務・戦略的SWOT分析
    Summary Select Medical Holdings Corp (Select Medical) is a healthcare service provider that offers outpatient rehabilitation services. The center provides long-term acute care services such as complex infectious disease treatment, respiratory failure, medically complex treatment, neurology, pulmonar …
  • China Development Bank
    China Development Bank - Strategy, SWOT and Corporate Finance Report Summary China Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Gamida Cell Ltd：企業のM&A・事業提携・投資動向
    Gamida Cell Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gamida Cell Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Coloplast AS (COLO B)：企業の財務・戦略的SWOT分析
    Coloplast AS (COLO B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆